Now I have all the data I need. Let me compile the final review.

**Round 1 bracketing:** Based on comparisons with anchors, the paper sits in the 4.0–6.0 range. It has stronger strengths (novelty favorability 11-13) than the 3-4 range papers (scMPT 3.40, LLM4GRN 4.33) but weaker evaluation than CellPLM (6.50). The two most comparable anchors are IFPCA+ (5.00) and the Single-Cell Foundation Model Evaluation benchmark (5.00).

**Narrowing:** Comparing itemized favorabilities: HypoGeneAgent's worst weakness (-2.46) is less severe than IFPCA+'s worst (-3.06) and αMax-B-CUBED's worst (-4.97), while its best strengths (13.63) exceed those anchors' best (9.40 and 12.94). This places it above both 5.00 anchors. But it falls short of CellPLM (6.50), whose weakest items stayed above 0 favorability.

**Final score:** 5.5.

---

## Summary

This paper proposes HypoGeneAgent, an LLM-driven framework that uses LLM-generated Gene Ontology annotations to guide clustering resolution selection in single-cell/Perturb-seq data. The approach derives two metrics — Intra-cluster Agreement (ICS) and Inter-cluster Distinctiveness (ICD) — from the LLM's GO hypotheses and combines them into a Resolution Score that is maximized when clusters are functionally coherent and distinct. The paper includes a two-stage evaluation: Stage 1 benchmarks LLM annotation quality on curated GOBP gene sets, and Stage 2 applies the method to resolution selection on a K562 Perturb-seq dataset.

## Strengths

- **The core idea is genuinely novel.** The paper proposes using LLM-generated functional annotations to guide clustering resolution selection — a creative bridge between two traditionally separate stages (unsupervised clustering and post-hoc annotation). Rather than relying on generic statistical criteria, the Resolution Score measures whether clusters can be described by distinct, internally coherent biological programs. [favorability=11.45]

- **The metric formulation is clean and mathematically precise.** Intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD) are well-defined and combined into a single Resolution Score. The use of sentence embeddings to compare free-text GO hypotheses is a reasonable engineering choice. [favorability=13.63]

- **The two-stage experimental design is methodologically appropriate.** Stage 1 benchmarks the LLM's annotation quality on curated GOBP gene sets before it is used for resolution selection, decoupling the question of LLM annotation quality from the question of resolution selection. The prompt engineering comparison (general vs. hypothesis prompts, V1 vs. V2) is a useful ablation. [favorability=11.48]

- **The paper provides a clean, reusable mathematical framework (ICS, ICD, Resolution Score)** that could be applied independently of the specific LLM used, making the approach modular and extensible. [favorability=9.65]

## Weaknesses

### Major

- **No external ground-truth validation of the resolution selection.** This is the paper's central problem. The claim that the Resolution Score selects "biologically more meaningful" resolutions (Abstract: "exhibits alignment with known pathway") is not supported by external biological ground truth. The paper shows that different metrics recommend different resolutions (Resolution Score: r=0.4/0.5, silhouette: r=0.5/0.6, modularity: r=0.7, GO enrichment: r=0.4/0.5), but provides no evidence that r=0.4 is biologically more correct than r=0.5, 0.6, or 0.7. The UMAP visualization ("nine well-separated clusters," Section 4.3) is subjective. The Replogle et al. (2022) Perturb-seq dataset has known perturbation effects that could serve as ground truth but are not used for validation. [favorability=-2.46]

- **The comparison against baselines does not support the paper's comparative claims.** The paper treats the fact that different metrics give different answers as evidence that the Resolution Score is superior, but does not quantitatively demonstrate superiority. The functional enrichment "validation" (Section 4.4.3) applies the same ICS/ICD/Resolution Score framework to enrichment p-values, so agreement between the two methods does not constitute independent validation — it only shows that the same mathematical framework applied to two annotation sources yields consistent results. Additionally, MultiK (Liu et al., 2021) — a biology-aware resolution selection method — is cited in Related Work but never used as a baseline. [favorability=-1.79]

### Minor

- **The Resolution Score depends entirely on the LLM's own annotations.** If the LLM produces confidently wrong, repetitive, or generic GO terms, ICS could be artificially high and ICD artificially low, yielding a high Resolution Score for a biologically meaningless clustering. While Stage 1 benchmarks show the LLM can produce reasonable annotations (AUC up to 0.743 for GPT-o3), this modest AUC means the best model still fails to rank ground-truth GO terms above random for ~25% of cases, and there is no mechanism to detect when annotations are unreliable. [favorability=0.32]

- **The AUC analysis for LLM annotation quality (max 0.743)** means the best model still fails to correctly rank the ground-truth GO term above random for approximately 25% of test cases. This modest performance should give pause about using these annotations as the sole signal for resolution selection. [favorability=3.46]

- **The weight hyperparameter w** (w=1/3) is selected by a "small grid search." The paper notes (Section 4.3) that different w values can give different resolution preferences for different clusters (Figure S5). While the paper claims w=1/3 "was found to give a stable ordering of resolutions across data sets," this claim would be stronger with a more systematic stability analysis. [favorability=5.22]

### Trivial

None.

## Nice-to-Haves

- Add external biological validation using the Replogle et al. (2022) dataset's known perturbation effects as ground truth, comparing the biological coherence of clusters at resolutions selected by different metrics.
- Include MultiK or other biology-aware resolution selection methods as a baseline.
- Add quantitative metrics (e.g., enrichment p-values, mutual information with known functional categories) to compare the biological quality of clusters at different resolutions, rather than relying on visual inspection.
- Tone down comparative superiority claims in the abstract and conclusion to match the level of evidence provided.
- Provide a systematic stability analysis of the weight hyperparameter w across a wider range of values.
- Include runtime/cost analysis to support the claim of being "orders of magnitude faster than manual curation."

## Removed Points

1. **"Clustering procedure is under-described (number of PCs, k for kNN, marker selection)"** — The paper explicitly defers these details to the appendix ("Please refer to the Clustering procedure session in the appendix for more details," Section 3.2). The parser strips appendix content. Per hard rules, this is removed.
2. **"ICD measures similarity but is described as distinctiveness"** — The naming is mathematically consistent: ICD_k is defined as mean pairwise similarity, and the Resolution Score uses 1-ICD_k to reward distinctiveness. The paper correctly describes the formulation.
3. **"Stage 1 evaluation doesn't test the paper's claimed contribution"** — This is a restatement of the ground-truth validation weakness, not a separate issue.
4. **Various general speculation about confounders and hypothetical failure modes** without specific evidence from the paper — removed per filtering discipline.
5. **Formatting nitpicks and reproduction-detail complaints** about appendix-deferred content — removed per hard rules.

## Novel Insights

The key insight from combining the reviews is that this paper's fundamental contribution — using LLM-generated functional annotations as an optimization criterion for clustering resolution — is genuinely novel and well-formalized, but the evaluation does not rise to the level needed to support the comparative superiority claims being made. The central tension is between the strength of the idea and the conclusiveness of the evidence. A version that adds external biological validation — for example, using the known perturbation effects in the Replogle et al. (2022) dataset to quantitatively compare whether clusters at the Resolution Score's preferred resolution better group functionally related perturbations than clusters at alternative resolutions — would substantially strengthen the paper.

## Suggestions

1. Add external biological validation using known perturbation effects as ground truth. For each resolution, compute whether the perturbation clustering groups functionally related perturbations together better than chance, and compare this quantitatively across resolutions selected by different metrics.
2. Provide a systematic stability analysis of the weight hyperparameter w across the full [0,1] range.
3. Include MultiK or other biology-aware resolution selection methods as baselines.
4. Add quantitative comparison metrics (enrichment precision, mutual information with known functional categories) to replace subjective visual inspection.
5. Calibrate comparative claims in the abstract and conclusion to match the level of evidence provided.

## Score and Decision

**Calibration anchors used (all rounds):**

| Paper | Path | Avg. Score | Round | Itemized? | Comparison |
|---|---|---|---|---|---|
| scMPT | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/nUpM7egYFd.md` | 3.40 | R1 | Yes | Weaker technical contribution; HypoGeneAgent's novelty stronger |
| LLM4GRN | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/jLd7OyAD4Y.md` | 4.33 | R1 | Yes | Similar validation gaps, but HypoGeneAgent's formulation cleaner |
| ZerOmics | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/J1xtkJmFY3.md` | 4.67 | R1 | Yes | Similar pattern of interesting approach but insufficient validation |
| αMax-B-CUBED | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/oyFCgkkLUK.md` | 4.75 | R2 | Yes | Similar metric paper; weaker strengths than HypoGeneAgent |
| IFPCA+ | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/rSAPrQzoQa.md` | 5.00 | R1 | Yes | Comparable — novel method but incomplete evaluation |
| Single-Cell FM Eval | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/iOltCu4TPS.md` | 5.00 | R2 | Yes | Benchmark paper; different contribution type |
| CellPLM | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/BKXvPDekud.md` | 6.50 | R1 | Yes | Stronger evaluation; accepted — HypoGeneAgent below this |
| IC\|TC (Image Clustering) | `/home/wg25r/split_review_opus_repro/datasets/deepreview_13k_calibration/G2cG3mQqop.md` | 7.00 | R1 | No | Higher score due to rigorous evaluation; conceptually similar idea |

**Round 1 bracket:** 4.0–6.0, based on similarity to LLM4GRN (4.33), ZerOmics (4.67), IFPCA+ (5.00), and below CellPLM (6.50).

**Round 2 narrowing:** The paper's strength favorabilities (11.45–13.63) exceed those of all anchors in the 4–5 range (max 9.40 for IFPCA+, max 12.94 for αMax-B-CUBED), while its worst weakness (-2.46) is less severe than the worst items in those papers. This places it above 5.0. However, its evaluation gap is real and prevents reaching CellPLM territory (6.50), where no weakness fell below 0 favorability. Hence the final score of 5.5.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>